Stryker (SYK) Liabilities and Shareholders Equity (2009 - 2026)
Stryker's (SYK) quarterly Liabilities and Shareholders Equity came in at $47.9 billion in Q2 2026, up 3.45% year-over-year from $46.3 billion in Q2 2025, and up 3.54% quarter-over-quarter from $46.3 billion in Q1 2026.
Analysis
Stryker (SYK) Liabilities and Shareholders Equity (2009 - 2026) Analysis & Trends
Stryker (SYK) has reported Liabilities and Shareholders Equity for 18 consecutive years, with $47.9 billion the latest figure, recorded in Q2 2026.
- On a quarterly basis, Liabilities and Shareholders Equity rose 3.45% year-over-year to $47.9 billion in Q2 2026; TTM through Jun 2026 was $189.1 billion, a 5.57% increase from a year earlier, with the FY2025 full-year figure at $47.8 billion, up 11.34% from the prior year.
- Liabilities and Shareholders Equity was $47.9 billion for Q2 2026 at Stryker, up from $46.3 billion in the prior quarter.
- Over five years, Liabilities and Shareholders Equity peaked at $47.9 billion in Q2 2026 and troughed at $36.0 billion in Q3 2022.
- A 5-year average of $41.3 billion and a median of $39.7 billion in 2023 frame the typical range for Liabilities and Shareholders Equity.
- Across the five-year window, Liabilities and Shareholders Equity rose 18.4% in 2025 and climbed 0.62% in 2026, its largest moves.
- Over 5 years, Liabilities and Shareholders Equity stood at $36.9 billion in 2022, then advanced by 8.21% to $39.9 billion in 2023, then gained by 7.66% to $43.0 billion in 2024, then rose by 11.34% to $47.8 billion in 2025, then climbed by 0.18% to $47.9 billion in 2026.
- The last three Liabilities and Shareholders Equity figures came in at $47.9 billion (Q2 2026), $46.3 billion (Q1 2026), and $47.8 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 109.22 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 20.88 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 93.31 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 47.93 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 45.22 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 13.87 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 31.10 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 6.46 Bn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 10.74 Bn |
| 10 | Zimmer Biomet Holdings | 18.20 Bn | 17.79 Bn | 1.54 Bn | 22.80 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 47.93 Bn |
| Mar 31, 2026 | 46.29 Bn |
| Dec 31, 2025 | 47.84 Bn |
| Sep 30, 2025 | 47.06 Bn |
| Jun 30, 2025 | 46.33 Bn |
| Mar 31, 2025 | 46.01 Bn |
| Dec 31, 2024 | 42.97 Bn |
| Sep 30, 2024 | 43.83 Bn |
| Jun 30, 2024 | 39.13 Bn |
| Mar 31, 2024 | 39.40 Bn |
| Dec 31, 2023 | 39.91 Bn |
| Sep 30, 2023 | 38.04 Bn |
| Jun 30, 2023 | 37.41 Bn |
| Mar 31, 2023 | 36.83 Bn |
| Dec 31, 2022 | 36.88 Bn |
| Sep 30, 2022 | 35.98 Bn |
| Jun 30, 2022 | 36.03 Bn |
| Mar 31, 2022 | 36.14 Bn |
| Dec 31, 2021 | 34.63 Bn |
| Sep 30, 2021 | 34.15 Bn |